Healthcare Pharmaceuticals

Healthcare Pharmaceuticals is a Bangladesh-based pharmaceutical manufacturer focused primarily on branded generic medicines for domestic and export markets. The company began through distribution of Roche products and later built its own manufacturing base, and it now markets a broad portfolio spanning cardiovascular, anti-infective, CNS, respiratory, diabetes, dermatology, ophthalmic, oncology, and biotech-related therapies. HPL operates multiple dosage-form and specialty manufacturing units, including oncology, cephalosporin, hormone, sterile/ophthalmic, and inhaler facilities, and has highlighted international GMP credentials including EU GMP for oncology. In addition to conventional generics, the company commercializes selected biologic and oncology products such as rituximab, tocilizumab, erythropoietin alfa, filgrastim, pegfilgrastim, etanercept, adalimumab, and pembrolizumab products for its market. The business appears oriented toward large-scale manufacturing, regulatory expansion, and exports rather than novel drug discovery.